THEY SAID IT! R STREET CALLS FOR BIPARTISAN, MARKET-BASED SOLUTIONS TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Oct 14, 2026
Article Highlights How Congress Can Address Patent Thickets, Product Hopping… Read More
© 2026 CSRXP- All Rights Reserved
They Said It
THEY SAID IT! LAWMAKERS HIGHLIGHT IMPORTANCE OF GREATER COMPETITION TO LOWER PRESCRIPTION DRUG PRICES AT U.S. SENATE HELP COMMITTEE MARKUP
Jun 18, 2026
Lawmakers Advance Bipartisan Solutions to Hold Big Pharma Accountable for… Read More
THEY SAID IT! LAWMAKERS AND EXPERTS SUPPORT BIPARTISAN, MARKET-BASED SOLUTIONS TO LOWER DRUG PRICES, FOSTER GREATER COMPETITION
Jun 5, 2026
U.S. House Judiciary Subcommittee Hearing Builds Bipartisan Momentum for ETHIC… Read More
THEY SAID IT! BROAD BASED SUPPORT FOR BIPARTISAN ETHIC ACT AND SKINNY LABELS, BIG SAVINGS ACT
Jun 2, 2026
Health Care Leaders and Policy Experts Agree Bipartisan, Market-Based… Read More
THEY SAID IT! “HOW PHARMA WEAPONIZES A WORD TO EXTEND MONOPOLIES”
May 28, 2026
Big Pharma Hides Behind False Innovation Rhetoric to Maintain Rampant Abuse of… Read More
THEY SAID IT! R STREET: “RESTORING THE MARKET FOR LOWER PRICE DRUGS”
May 27, 2026
Analysis Details How Big Pharma’s Patent Abuse Delays Generic and Biosimilar… Read More
THEY SAID IT! U.S. SENATORS URGE FDA TO FURTHER CRACK DOWN ON BIG PHARMA’S DTC ADVERTISING
Apr 13, 2026
Bipartisan Letter Targets Big Pharma’s Misleading Ads That Inflate Costs And… Read More
THEY SAID IT! HHS OFFICIAL: “COMPETITION IS AN INCREDIBLY EFFECTIVE TOOL TO ADDRESS HIGH DRUG PRICES”
Mar 27, 2026
Administration Touts Positive Steps to Bring More Biosimilars to Market… Read More
THEY SAID IT! LAWMAKERS AND EXPERTS CALL OUT BIG PHARMA’S ANTI-COMPETITIVE PLAYBOOK, URGE CONGRESS TO BOOST GENERIC AND BIOSIMILAR COMPETITION
Feb 12, 2026
U.S. House Energy & Commerce Health Subcommittee Hearing Puts Big Pharma… Read More
THEY SAID IT! U.S. REPRESENTATIVE DAVE TAYLOR CALLS FOR LIST PRICE TRANSPARENCY IN BIG PHARMA’S DIRECT-TO-CONSUMER ADVERTISING
Dec 17, 2025
Lawmaker Highlights Broad-Based Support for Bipartisan Solution to Disclose… Read More
THEY SAID IT! BIPARTISAN GROUP OF LAWMAKERS URGE ADMINISTRATION TO SUPPORT CRACKDOWN ON BIG PHARMA’S PATENT THICKETS
Dec 16, 2025
Members of Congress Say Addressing “Patent Thickets Surrounding Branded… Read More
THEY SAID IT!: ADMINISTRATION HIGHLIGHTS HOW BIG PHARMA GAMES THE SYSTEM TO UNDERMINE BIOSIMILAR COMPETITION, KEEP PRESCRIPTION DRUG PRICES HIGH
Nov 6, 2025
HHS, FDA and CMS Leaders Emphasize How Streamlining Biosimilar Approvals Will… Read More